Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04251533
Title Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | AUT

Facility Status City State Zip Country Details
Cancer and Blood Specialty Clinic Los Alamitos California 90720 United States Details
UCLA Medical Center Santa Monica Location Los Angeles California 90095 United States Details
Florida Cancer Specialists Dept of Oncology (2) Fort Myers Florida 33901 United States Details
Hematology and Oncology Clinic SC Baton Rouge Louisiana 70809 United States Details
Mayo Clinic Rochester Mayo - Roch. Rochester Minnesota 55905 United States Details
Park Nicollet Institute Dept Onc Saint Louis Park Minnesota 55416 United States Details
University of Pittsburgh Cancer Institute Cancer Pavilion, 5th floor Pittsburgh Pennsylvania 15232 United States Details
Tennessee Oncology Tennessee Oncology (3) Nashville Tennessee 37203 United States Details
Texas Oncology PA Dallas Presbyterian Hospital SC Dallas Texas 75231 United States Details
Texas Oncology Texas Oncology - Denton Dallas Texas 75246 United States Details
Cancer Care Centers of South Texas HOAST CCC of So. TX- San Antonio San Antonio Texas 78229 United States Details
Novartis Investigative Site Caba Buenos Aires C1125ABD Argentina Details
Novartis Investigative Site Caba Buenos Aires C1280AEB Argentina Details
Novartis Investigative Site Caba Buenos Aires C1426ANZ Argentina Details
Novartis Investigative Site Buenos Aires Caba C1431FWO Argentina Details
Novartis Investigative Site Rosario Santa Fe S2000KZE Argentina Details
Novartis Investigative Site Rio Negro Viedma 8500 Argentina Details
Novartis Investigative Site Darlinghurst New South Wales 2010 Australia Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Murdoch Western Australia 6150 Australia Details
Novartis Investigative Site Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Leoben A 8700 Austria Details
Novartis Investigative Site Caxias do Sul RS 95070-560 Brazil Details
Novartis Investigative Site Barretos SP 14784 400 Brazil Details
Novartis Investigative Site Sao Paulo SP 01317-002 Brazil Details
Novartis Investigative Site Sao Paulo SP 04014-002 Brazil Details
Novartis Investigative Site Plovdiv 4004 Bulgaria Details
Novartis Investigative Site Varna 9010 Bulgaria Details
Novartis Investigative Site Hefei Anhui 230001 China Details
Novartis Investigative Site Chongqing Chongqing 404100 China Details
Novartis Investigative Site Guangzhou Guangdong 510630 China Details
Novartis Investigative Site Guiyang Guizhou 550000 China Details
Novartis Investigative Site Shijiazhuang Hebei 050011 China Details
Novartis Investigative Site Harbin Heilongjiang 150081 China Details
Novartis Investigative Site Wuhan Hubei 430022 China Details
Novartis Investigative Site Changsha Hunan 410013 China Details
Novartis Investigative Site Nanjing Jiangsu 210029 China Details
Novartis Investigative Site Nanchang Jiangxi 330009 China Details
Novartis Investigative Site Chang Chun Jilin 130021 China Details
Novartis Investigative Site Shengyang Liaoning 110042 China Details
Novartis Investigative Site Jinan Shandong 250117 China Details
Novartis Investigative Site Xian Shanxi 710061 China Details
Novartis Investigative Site Chengdu Sichuan 610041 China Details
Novartis Investigative Site Tianjin Tianjin 300060 China Details
Novartis Investigative Site Hangzhou Zhejiang 310016 China Details
Novartis Investigative Site Hangzhou Zhejiang 310022 China Details
Novartis Investigative Site Dalian China Details
Novartis Investigative Site Qingdao 266000 China Details
Novartis Investigative Site Shanghai 200025 China Details
Novartis Investigative Site Shenyang 110001 China Details
Novartis Investigative Site Rionegro Antioquia 054047 Colombia Details
Novartis Investigative Site Bogota 110221 Colombia Details
Novartis Investigative Site Bogota 110231 Colombia Details
Novartis Investigative Site Zagreb 10000 Croatia Details
Novartis Investigative Site Saint-Cloud Hauts De Seine 92210 France Details
Novartis Investigative Site Angers Cedex 02 49055 France Details
Novartis Investigative Site Besancon Cedex 25030 France Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Clermont Ferrand 63011 France Details
Novartis Investigative Site Creteil 94010 France Details
Novartis Investigative Site Dijon 21034 France Details
Novartis Investigative Site Le Mans 72000 France Details
Novartis Investigative Site Metz 57085 France Details
Novartis Investigative Site Paris Cedex 10 75475 France Details
Novartis Investigative Site Poitiers 86000 France Details
Novartis Investigative Site Reims 51100 France Details
Novartis Investigative Site Saint-Herblain Cédex 44805 France Details
Novartis Investigative Site Villejuif Cedex 94800 France Details
Novartis Investigative Site Essen Nordrhein-Westfalen 45136 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Erlangen 91054 Germany Details
Novartis Investigative Site Leipzig 04103 Germany Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Budapest 1062 Hungary Details
Novartis Investigative Site Budapest H 1122 Hungary Details
Novartis Investigative Site Debrecen 4032 Hungary Details
Novartis Investigative Site Kecskemet 6000 Hungary Details
Novartis Investigative Site Tatabanya H 2800 Hungary Details
Novartis Investigative Site Faridabad Haryana 121 001 India Details
Novartis Investigative Site Mumbai Maharashtra 400 053 India Details
Novartis Investigative Site Mumbai Maharashtra 400056 India Details
Novartis Investigative Site Vellore Tamil Nadu 632 004 India Details
Novartis Investigative Site Hyderabad Telangana 500034 India Details
Novartis Investigative Site Kolkata West Bengal 700160 India Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Ancona AN 60126 Italy Details
Novartis Investigative Site Brindisi BR 72100 Italy Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Messina ME 98158 Italy Details
Novartis Investigative Site Rionero in Vulture PZ 85028 Italy Details
Novartis Investigative Site Roma RM 00128 Italy Details
Novartis Investigative Site Roma RM 00168 Italy Details
Novartis Investigative Site Torino TO 10126 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 05505 Korea, Republic of Details
Novartis Investigative Site Seoul 06351 Korea, Republic of Details
Novartis Investigative Site Petaling Jaya Selangor 46050 Malaysia Details
Novartis Investigative Site Kuala Lumpur 59100 Malaysia Details
Novartis Investigative Site Tuxtla Gutierrez Chiapas 29038 Mexico Details
Novartis Investigative Site Ciudad De Mexico Distrito Federal 04980 Mexico Details
Novartis Investigative Site Monterrey Nuevo Leon 64460 Mexico Details
Novartis Investigative Site Oslo NO 0450 Norway Details
Novartis Investigative Site Stavanger 4019 Norway Details
Novartis Investigative Site Tromsoe 9038 Norway Details
Novartis Investigative Site Trujillo La Libertad Peru Details
Novartis Investigative Site Lima 33 Peru Details
Novartis Investigative Site Lima Lima 31 Peru Details
Novartis Investigative Site Gdynia 81 519 Poland Details
Novartis Investigative Site Opole 45-061 Poland Details
Novartis Investigative Site Poznan 61 485 Poland Details
Novartis Investigative Site Rzeszow 35-021 Poland Details
Novartis Investigative Site Arkhangelsk 163045 Russian Federation Details
Novartis Investigative Site Chelyabinsk 454048 Russian Federation Details
Novartis Investigative Site Moscow 117997 Russian Federation Details
Novartis Investigative Site Moscow 123056 Russian Federation Details
Novartis Investigative Site Pushkin Saint Petersburg 196603 Russian Federation Details
Novartis Investigative Site Belgrade 11000 Serbia Details
Novartis Investigative Site Nis 18000 Serbia Details
Novartis Investigative Site Bratislava Slovak Republic 83310 Slovakia Details
Novartis Investigative Site Bratislava 812 50 Slovakia Details
Novartis Investigative Site Kosice 041 91 Slovakia Details
Novartis Investigative Site Ljubljana 1000 Slovenia Details
Novartis Investigative Site Port Elizabeth Western Cape 6045 South Africa Details
Novartis Investigative Site Johannesburg 2196 South Africa Details
Novartis Investigative Site Pretoria 0081 South Africa Details
Novartis Investigative Site Almeria Andalucia 04009 Spain Details
Novartis Investigative Site Sabadell Barcelona 08208 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Alicante Comunidad Valenciana 03010 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46017 Spain Details
Novartis Investigative Site Badajoz Extremadura 06080 Spain Details
Novartis Investigative Site Palma De Mallorca Islas Baleares 07120 Spain Details
Novartis Investigative Site Ferrol 15405 Spain Details
Novartis Investigative Site Santa Cruz de Tenerife 38009 Spain Details
Novartis Investigative Site Valencia 46026 Spain Details
Novartis Investigative Site Bern 3010 Switzerland Details
Novartis Investigative Site Lausanne 1011 Switzerland Details
Novartis Investigative Site Zurich 8008 Switzerland Details
Novartis Investigative Site Kaoshiung 83301 Taiwan Details
Novartis Investigative Site Taichung 40447 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taipei 10449 Taiwan Details
Novartis Investigative Site Taoyuan 33305 Taiwan Details
Novartis Investigative Site Adana 01250 Turkey Details
Novartis Investigative Site Ankara 06100 Turkey Details
Novartis Investigative Site Istanbul 34722 Turkey Details
Novartis Investigative Site Istanbul 35100 Turkey Details
Novartis Investigative Site Izmir 35040 Turkey Details
Novartis Investigative Site Talas / Kayseri 38039 Turkey Details
Novartis Investigative Site Nottingham NG5 1PB United Kingdom Details
Novartis Investigative Site Oxford OX3 7LJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field